Skip to main content
AmigoFish

Biosimilar products (Ep. 25)

From Clinical Pharmacology Podcast with Nathan Teuscher · · 16 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

Today’s show discussed biosimilar development from a clinical pharmacology perspective. I describe what biosimilar products are and the necessary comparisons to the reference product. I review requirements for PK similarity, PD similarity, immunogenicity, and safety. I also touch on the idea of interchangeability between the biosimilar and reference products.

Links discussed in the show:

- FDA Guidance on Clinical Pharmacology Data to support Biosimilarity (https://go.teuschersolutions.com/biosim1) (May 2016)

- FDA Guidance on Demonstrating Interchangeability (https://go.teuschersolutions.com/biosim2) (May 2019)

- FDA Q&A on Biosimilarity and Interchangeability (https://go.teuschersolutions.com/biosim3) (Sep 2023)

- You can connect with me on LinkedIn (https://go.teuschersolutions.com/linkedin) and send me a message

- Send me a message (https://go.teuschersolutions.com/contact)

- Sign up for my newsletter (https://go.teuschersolutions.com/newsletter)

Copyright Teuscher Solutions LLC

All Rights Reserved

Back to Clinical Pharmacology Podcast with Nathan Teuscher · Report a problem